Best semax Peptides GMP Factor

Semax

Semax

Other names:L-Methionyl-L-α-glutamylhistidyl-L-phenylalanyl-L-prolylglycyl-L-proline, (Pro8,Gly9,Pro10)ACTH-(4-10)

Semax is a nootropic drug from the group of neuropeptides. Semax is a drugwhich is used mostly in Russia for a broad range of conditions but predominantly for its purported nootropic, neuroprotective, and neurorestorative properties. Semax include treatment of stroke, transient ischemic attack, memory and cognitive disorders, peptic ulcers, optic nerve disease, and to boost the immune system.

Production capacity: Provide customization

Large Factory Professional Manufacturers & Factory

Production Carried OUT Under CGMP Regulation and Trackable

ISO9001 & ISO14000

Get a Bulk quotation

If you need a larger quantity. Please fill in the form, our BD (Business Development) will provide you with a competitive quotation.

Semax Peptide dosage calculator

Referenced Citations

[1] Yatsenko KA, Glazova NY, Inozemtseva LS, Andreeva LA, Kamensky AA, Grivennikov IA, et al. (November 2013). “Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats”. Doklady Biological Sciences. 453: 353–357. doi:10.1134/S0012496613060161. PMID 24385169. S2CID 9699654. 

[2] Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, et al. (March 2012). “Semax attenuates the influence of neonatalmaternal deprivation on the behavior of adolescent white rats”. Bulletin of Experimental Biology and Medicine. 152 (5): 560–563. doi:10.1007/s10517-012-1574-2. PMID 22803132. S2CID 1419653.

[3] Pae CU (January 2008). “Therapeutic possibility of “Semax” for depression”.CNS Spectrums. 13 (1): 20–21. doi:10.1017/S1092852900016102. PMID 18204410.

[4] Bertolini A (March 2012). “Drug-induced activation of the nervous control of inflammation: a novel possibility for the treatment of hypoxic damage”. European Journal of Pharmacology. 679 (1–3): 1–8. doi:10.1016/j.ejphar.2012.01.004. PMID 22293371.

[5] Kost NV, Sokolov OI, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA (2001). “Semax and selank inhibit the enkephalin-degrading enzymes from human serum”. Bioorganicheskaia Khimiia (in Russian). 27 (3): 180–183. doi:10.1023/A:1011373002885. PMID 11443939. S2CID 26029820.

[6] Lebedeva IS, Panikratova YR, Sokolov OY, Kupriyanov DA, Rumshiskaya AD, Kost NV, Myasoedov NF (September 2018). “Effects of Semax on the Default Mode Network of the Brain”. Bulletin of Experimental Biology and Medicine. 165 (5): 653–656. doi:10.1007/s10517-018-4234-3. PMID 30225715. S2CID 254292493.

[7] Kaplan AY, Kochetova AG, Nezavibathko VN, Rjasina TV, Ashmarin IP (September 1996). “Synthetic acth analogue semax displays nootropic‐like activity in humans”. Neuroscience Research Communications. 19 (2): 115–123. doi:10.1002/(SICI)1520-6769(199609)19:2<115::AID-NRC171>3.0.CO;2-B.

[8] Gusev EI, Martynov MY, Kostenko EV, Petrova LV, Bobyreva SN (2018). “[The efficacy of semax in the tretament of patients at different stages of ischemic stroke]”. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 118 (3. Vyp. 2): 61–68. doi:10.17116/jnevro20181183261-68. PMID 29798983.

[9] Kurysheva NI, Shpak AA, Ioĭleva EE, Galanter LI, Nagornova ND, Shubina NI, Shlyshalova NN (2001). “[Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone]”. Vestnik Oftalmologii. 117 (4): 5–8. PMID 11569188.

[10] Ivanikov IO, Brekhova ME, Samonina GE, Myasoedov NF, Ashmarin IP (July 2002). “Therapy of peptic ulcer with semax peptide”. Bulletin of Experimental Biology and Medicine. 134 (1): 73–74. doi:10.1023/A:1020621124776. PMID 12459874. S2CID 23447014.

[11] Korneev EA, Kazakova TB (1999). “Current approaches to the analysis of the effects of stress on metabolic processes in cells of the nervous and immune systems”. Med. Immunology. 1 (1–2): 17–22.

[12] Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, et al. (October 2006). “Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus”. Brain Research. 1117 (1): 54–60. doi:10.1016/j.brainres.2006.07.108. PMID 16996037. S2CID 27592503.

[13] Eremin KO, Kudrin VS, Grivennikov IA, Miasoedov NF, Rayevsky KS (2004). “Effects of Semax on dopaminergic and serotoninergic systems of the brain”. Doklady Biological Sciences. 394 (1–6): 1–3. doi:10.1023/b:dobs.0000017114.24474.40. PMID 15088389. S2CID 12955434.

[14] Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS (December 2005). “Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents”. Neurochemical Research. 30 (12): 1493–1500. doi:10.1007/s11064-005-8826-8. PMID 16362768. S2CID 38202287.

[15] Vilenskiĭ DA, Levitskaia NG, Andreeva LA, Alfeeva LI, Kamenskiĭ AA, Miasoedov NF (June 2007). “[Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats]”. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova (in Russian). 93 (6): 661–669. PMID 17850024.

Author of this article:

Dr. Jean Zeng graduated from king’s college london Faculty of Life Sciences & Medicine. 

Scientific Journal paper Author:

  1. Nataliya Yu. Glazova

Institute of Molecular Genetics, RAS, 2 Akademika Kurchatova square, Moscow 123182, Russia 

  1. Glazova

National Research Centre “Kurchatov Institute”, Institute of Molecular Genetics, Moscow, Russian Federation

  1. Levitskaya

Lomonosov Moscow State University, Biological- Human and Animal phisiology, Moscow, Russian Federation

  1. Cristina Satriano

Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Viale A. Doria 6, 95125 Catania, Italy

  1. Valeria Lanza

CNR-Istituto di Biostrutture e Bioimmagini, Via P. Gaifami 18, 95126 Catania, Italy

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. peptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.

Author of this article:

Dr. Jean Zeng graduated from king's college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

Stephen C. Bain
Diabetes Research Group, Swansea University Medical School, Swansea, SA2 8PP, UK
Department of Diabetes and Endocrinology, Singleton Hospital, Swansea Bay University Health Board, Swansea, SA2 8QA, UK

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Polypeptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.